Talking Point – MOXY: An open label pilot study of oxytocin for methamphetamine withdrawal in women
Zoom webinarTalking Point - 21st August 2024, 1pm - 2pm - ONLINE MOXY: An open label pilot study of oxytocin for methamphetamine withdrawal in women, presented by Dr Sarah Catchlove, Research Fellow, Turning Point & A/Prof Shalini Arunogiri, Clinical Director, Turning Point Statewide Services. This presentation will provide an overview of the results of a recently completed